Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399)Versus Docetaxel in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, LocallyAdvanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Kulkarni, Amit A (PI)
Project: Research project